Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.300 | 3.320 | 0.020 |
Stocks | 68.960 | 69.040 | 0.080 |
Bonds | 26.400 | 28.080 | 1.680 |
Convertible | 0.010 | 0.010 | 0.000 |
Preferred | 0.010 | 0.010 | 0.000 |
Other | 1.330 | 1.390 | 0.060 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.764 | 18.522 |
Price to Book | 2.679 | 3.158 |
Price to Sales | 1.790 | 2.191 |
Price to Cash Flow | 11.067 | 12.245 |
Dividend Yield | 2.003 | 1.988 |
5 Years Earnings Growth | 10.834 | 11.568 |
Name | Net % | Category Average |
---|---|---|
Technology | 27.370 | 23.559 |
Financial Services | 12.660 | 15.025 |
Consumer Cyclical | 11.170 | 9.803 |
Healthcare | 10.780 | 13.325 |
Industrials | 9.890 | 10.410 |
Communication Services | 8.410 | 7.286 |
Consumer Defensive | 6.390 | 6.283 |
Real Estate | 3.880 | 4.402 |
Energy | 3.740 | 5.224 |
Basic Materials | 3.480 | 3.443 |
Utilities | 2.220 | 3.204 |
Number of long holdings: 4
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Stadion Flex 8 | - | 39.73 | - | - | |
Stadion Core Income CL 8 | - | 30.43 | - | - | |
Stadion Domestic Equity CL 8 | - | 19.38 | - | - | |
Stadion International Equity CL 8 | - | 10.53 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Stadion Growth Fund CL 5 | 84.55M | -0.03 | 4.34 | 6.75 | ||
Benefit FCI Life Strategy Growth Fa | 44.99M | 0.06 | 4.63 | 7.63 | ||
Benefit FCI Life Strategy Growth Fb | 20.35M | 0.04 | 4.42 | 7.41 | ||
Stadion Moderate Growth 1 | 8.23M | -0.01 | 3.38 | 5.75 | ||
Stadion Growth Fund CL 1 | 7.46M | -0.04 | 4.25 | 6.73 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review